ytoplasmic dynein associates with a variety of intracellular cargos and pulls them toward the minus ends of microubules. But this retrograde motor protein is also essential for forward cell migration, as Dujardin et al. demonstrate on page 1205.
After observing dynein and its associated regulatory proteins at the leading edges of migrating cells in a monolayer model of wound healing, the authors inhibited dynein activity at various times to identify its functions. Early in cell migration, dynein helps reorganize the microtubule cytoskeleton, placing the centrosome on the leading edge side of the nucleus. Once this rearrangement is completed, inhibiting dynein does not change the location of the centrosome.
The motor protein is still required for cell migration even after cytoskeletal rearrangement. During migration, dynein appears in a diffuse area along the leading edge of the cell, where it seems to capture the plus ends of microtubules that enter the region. It is unclear whether dynein at the leading edge is activating lamellipodial protrusion or serving a strictly mechanical function, but the mechanism might have parallels with the action of dynein at the kinetochore, where it both pulls on microtubules and participates in mitotic checkpoint signaling.
C Dynein (green) at the front of the cell helps the cell move.
Neural progenitors find VEGF attractive
lood vessels and neural stem cells can be led to their targets by the same factor, say Zhang et al. on page 1375. The factor, vascular endothelial growth factor A (VEGF), is known as a major inducer of angiogenesis. Zhang et al. show that it is also a powerful attractant for immature neural progenitor cells. In the developing mammalian brain, it may be used when both neural stem cell migration and blood vessel growth must head for the same brain region.
The authors purified neural progenitors from the subventricular zones of newborn rats, and cultured them in the presence of fibroblast growth factor 2 (FGF-2) to prevent them from differentiating. The progenitor cells migrate up gradients of VEGF, in a chemotactic response specifically mediated by VEGF receptor 2. In cocultures in three-dimensional collagen matrices, the progenitors migrate toward VEGF-secreting cells. Progenitor cells that are allowed to differentiate into neuron-or gliarestricted lineages become insensitive to VEGF.
The data suggest that VEGF links angiogenesis to neurogenesis to establish neurogenic niches within the developing brain. Once the niches are established by immature progenitors, they could act as launching points for migrations by more differentiated cells. VEGF and FGF-2 might be useful in treating brain injuries by directing transplanted progenitor cells to migrate into damaged areas.
B
Neural progenitors migrate toward VEGF.
Death and the shrinking nucleus
uring heart disease and stroke, cells deprived of oxygen often die in a way that is distinct from caspase-dependent apoptosis. On page 1219, Shinzawa and Tsujimoto provide a first look at the molecular basis of this poorly understood process, showing that a phospholipase A 2 (PLA 2 ) enzyme causes the characteristic nuclear shrinkage that accompanies hypoxic cell death.
Using a novel permeabilized cell assay, the authors purified a protein that can cause nuclear shrinkage and identified it as PLA 2 . Inhibitor studies confirmed that PLA 2 is essential for nuclear shrinkage in caspaseindependent hypoxic cell death. In hypoxic cells, PLA 2 activity increases and the calcium-independent form of the enzyme accumulates in the nucleus. Blocking calcium-independent PLA 2 activity prevents both nuclear shrinkage and hypoxic cell death.
An increase in PLA 2 activity leads to the cleavage of nuclear lamins, which could explain how it causes nuclear shrinkage. Since PLA 2 cleaves phospholipids, it could also contribute to cell death by disrupting mitochondrial and plasma membranes, processes the authors now hope to study biochemically. The identification of PLA 2 as an important mediator of caspase-independent death should also help uncover additional components of the pathway, such as the regulators of PLA 2 activity and translocation. D PLA 2 (right) shrinks nuclei during hypoxic death.
